Cancer Research SABCS  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 9954, October 15, 2007. doi: 10.1158/0008-5472.CAN-07-1478
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, B.
Right arrow Articles by Longley, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, B.
Right arrow Articles by Longley, B. J.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

MAGE-A, mMage-b, and MAGE-C Proteins Form Complexes with KAP1 and Suppress p53-Dependent Apoptosis in MAGE-Positive Cell Lines

Bing Yang1, Sean M. O'Herrin1, Jianqiang Wu1, Shannon Reagan-Shaw1, Yongsheng Ma1, Kumar M.R. Bhat1, Claudia Gravekamp4, Vijayasaradhi Setaluri1, Noel Peters2, F. Michael Hoffmann2, Hongzhuang Peng5, Alexey V. Ivanov5, Andrew J.G. Simpson3 and B. Jack Longley1,2

1 Department of Dermatology and 2 Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin Medical School, Madison, Wisconsin; 3 The Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan Kettering Cancer Institute, New York, New York; 4 California Pacific Medical Center Research Institute, San Francisco, California; and 5 The Wistar Institute, Philadelphia, Pennsylvania

Requests for reprints: Bing Yang and B. Jack Longley, Department of Dermatology, University of Wisconsin Medical School, Room B25, 1300 University Avenue, Madison, WI 53706. Phone: 608-263-7144; Fax: 608-263-5223; E-mail: byang{at}dermatology.wisc.edu.

The MAGE-A, MAGE-B, and MAGE-C protein families comprise the class-I MAGE/cancer testes antigens, a group of highly homologous proteins whose expression is suppressed in all normal tissues except developing sperm. Aberrant expression of class I MAGE proteins occurs in melanomas and many other malignancies, and MAGE proteins have long been recognized as tumor-specific targets; however, their functions have largely been unknown. Here, we show that suppression of class I MAGE proteins induces apoptosis in the Hs-294T, A375, and S91 MAGE-positive melanoma cell lines and that members of all three families of MAGE class I proteins form complexes with KAP1, a scaffolding protein that is known as a corepressor of p53 expression and function. In addition to inducing apoptosis, MAGE suppression decreases KAP1 complexing with p53, increases immunoreactive and acetylated p53, and activates a p53 responsive reporter gene. Suppression of class I MAGE proteins also induces apoptosis in MAGE-A–positive, p53wt/wt parental HCT 116 colon cancer cells but not in a MAGE-A–positive HCT 116 p53–/– variant, indicating that MAGE suppression of apoptosis requires p53. Finally, treatment with MAGE-specific small interfering RNA suppresses S91 melanoma growth in vivo, in syngenic DBA2 mice. Thus, class I MAGE protein expression may suppress apoptosis by suppressing p53 and may actively contribute to the development of malignancies and by promoting tumor survival. Because the expression of class I MAGE proteins is limited in normal tissues, inhibition of MAGE antigen expression or function represents a novel and specific treatment for melanoma and diverse malignancies. [Cancer Res 2007;67(20):9954–62]




This article has been cited by other articles:


Home page
Cancer Res.Home page
P.-C. Chang, L. D. Fitzgerald, A. Van Geelen, Y. Izumiya, T. J. Ellison, D.-H. Wang, D. K. Ann, P. A. Luciw, and H.-J. Kung
Kruppel-Associated Box Domain-Associated Protein-1 as a Latency Regulator for Kaposi's Sarcoma-Associated Herpesvirus and Its Modulation by the Viral Protein Kinase
Cancer Res., July 15, 2009; 69(14): 5681 - 5689.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
S. Cheng, W. Liu, M. Mercado, S. Ezzat, and S. L Asa
Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer
Endocr. Relat. Cancer, June 1, 2009; 16(2): 455 - 466.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Liu, S. Cheng, S. L. Asa, and S. Ezzat
The Melanoma-Associated Antigen A3 Mediates Fibronectin-Controlled Cancer Progression and Metastasis
Cancer Res., October 1, 2008; 68(19): 8104 - 8112.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. F. Gjerstorff, L. Harkness, M. Kassem, U. Frandsen, O. Nielsen, M. Lutterodt, K. Mollgard, and H. J. Ditzel
Distinct GAGE and MAGE-A expression during early human development indicate specific roles in lineage differentiation
Hum. Reprod., October 1, 2008; 23(10): 2194 - 2201.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.